Lars Erichsen

1.5k total citations · 2 hit papers
45 papers, 1.0k citations indexed

About

Lars Erichsen is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Lars Erichsen has authored 45 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 13 papers in Endocrinology, Diabetes and Metabolism and 6 papers in Surgery. Recurrent topics in Lars Erichsen's work include Epigenetics and DNA Methylation (10 papers), Diabetes Treatment and Management (7 papers) and Diabetes Management and Research (6 papers). Lars Erichsen is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Diabetes Treatment and Management (7 papers) and Diabetes Management and Research (6 papers). Lars Erichsen collaborates with scholars based in Germany, Denmark and United States. Lars Erichsen's co-authors include Hanne Haahr, Sue D. Pedersen, Thomas Danne, Thomas R. Pieber, Tim Heise, Kristian Vinter Juul, Chantal Mathieu, Srikanth Deenadayalan, Filip K. Knop and Ildiko Lingvay and has published in prestigious journals such as The Lancet, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Lars Erichsen

41 papers receiving 991 citations

Hit Papers

Efficacy and safety of co-administered once-weekly c... 2021 2026 2022 2024 2023 2021 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
    2023 193 citations Juan P. Frías, Srikanth Deenadayalan et al. The Lancet profile →
  2. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
    2021 162 citations David C.W. Lau, Lars Erichsen et al. The Lancet profile →

Peers

Lars Erichsen
Geneviève Escher Switzerland
Sunder Mudaliar United States
Takuhiro Sonoyama Japan
R Stoltz United States
H. L. Krüskemper Germany
Maria Mirabelli Italy
Richard W Simpson Australia
E. R. Ramey United States
Sabine Tunn Germany
Taku Tsunekawa Japan
Geneviève Escher Switzerland
Lars Erichsen
Citations per year, relative to Lars Erichsen Lars Erichsen (= 1×) peers Geneviève Escher

Countries citing papers authored by Lars Erichsen

Since Specialization
Citations

This map shows the geographic impact of Lars Erichsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Erichsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Erichsen more than expected).

Fields of papers citing papers by Lars Erichsen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Erichsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Erichsen. The network helps show where Lars Erichsen may publish in the future.

Co-authorship network of co-authors of Lars Erichsen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Erichsen. A scholar is included among the top collaborators of Lars Erichsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Erichsen. Lars Erichsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kordes, Claus, et al.. (2025). Human Urine-Derived SIX2-Positive Renal Progenitor Cells Partially Improve Kidney Fibrosis by Paracrine Signaling. Stem Cells and Development. 34(21-22). 472–482.
2.
Santourlidis, Simeon, et al.. (2024). Epigenetics Meets CAR-T-Cell Therapy to Fight Cancer. Cancers. 16(10). 1941–1941. 1 indexed citations
3.
Erichsen, Lars, et al.. (2023). Unveiling Angiotensin II and Losartan-Induced Gene Regulatory Networks Using Human Urine-Derived Podocytes. International Journal of Molecular Sciences. 24(13). 10551–10551. 2 indexed citations
4.
Erichsen, Lars, Wasco Wruck, Thomas Dimski, et al.. (2023). Secreted Cytokines within the Urine of AKI Patients Modulate TP53 and SIRT1 Levels in a Human Podocyte Cell Model. International Journal of Molecular Sciences. 24(9). 8228–8228. 2 indexed citations
5.
6.
Frías, Juan P., Srikanth Deenadayalan, Lars Erichsen, et al.. (2023). Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. The Lancet. 402(10403). 720–730. 193 indexed citations breakdown →
7.
Araúzo‐Bravo, Marcos J., et al.. (2022). Consistent DNA Hypomethylations in Prostate Cancer. International Journal of Molecular Sciences. 24(1). 386–386. 5 indexed citations
8.
Araúzo‐Bravo, Marcos J., et al.. (2022). Differential DNA Methylation of THOR and hTAPAS in the Regulation of hTERT and the Diagnosis of Cancer. Cancers. 14(18). 4384–4384. 3 indexed citations
9.
Santourlidis, Simeon, Wolfgang A. Schulz, Marcos J. Araúzo‐Bravo, et al.. (2022). Epigenetics in the Diagnosis and Therapy of Malignant Melanoma. International Journal of Molecular Sciences. 23(3). 1531–1531. 10 indexed citations
10.
Lau, David C.W., Lars Erichsen, Ann Marie Ocampo Francisco, et al.. (2021). Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. The Lancet. 398(10317). 2160–2172. 162 indexed citations breakdown →
11.
Erichsen, Lars, Hans‐Helge Seifert, Wolfgang A. Schulz, et al.. (2020). Basic Hallmarks of Urothelial Cancer Unleashed in Primary Uroepithelium by Interference with the Epigenetic Master Regulator ODC1. Scientific Reports. 10(1). 3808–3808. 10 indexed citations
12.
Rahman, Md Shaifur, Wasco Wruck, Lucas‐Sebastian Spitzhorn, et al.. (2020). The FGF, TGFβ and WNT axis Modulate Self-renewal of Human SIX2+ Urine Derived Renal Progenitor Cells. Scientific Reports. 10(1). 739–739. 33 indexed citations
13.
Erichsen, Lars, Foued Ghanjati, Cédric Poyet, et al.. (2018). Aberrant methylated key genes of methyl group metabolism within the molecular etiology of urothelial carcinogenesis. Scientific Reports. 8(1). 3477–3477. 11 indexed citations
14.
15.
Erichsen, Lars, Marcos J. Araúzo‐Bravo, Mohamed Hassan, et al.. (2018). Genome-wide hypomethylation of LINE-1 and Alu retroelements in cell-free DNA of blood is an epigenetic biomarker of human aging. Saudi Journal of Biological Sciences. 25(6). 1220–1226. 35 indexed citations
16.
Heise, Tim, Thomas R. Pieber, Thomas Danne, Lars Erichsen, & Hanne Haahr. (2017). A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes. Clinical Pharmacokinetics. 56(5). 551–559. 130 indexed citations
17.
Al‐Quraishy, Saleh, Mohamed A. Dkhil, Abdel‐Azeem S. Abdel‐Baki, et al.. (2017). Protective vaccination and blood-stage malaria modify DNA methylation of gene promoters in the liver of Balb/c mice. Parasitology Research. 116(5). 1463–1477. 10 indexed citations
18.
19.
Erichsen, Lars, Olorunsola F. Agbaje, Stephen D. Luzio, David R. Owens, & Roman Hovorka. (2004). Population and individual minimal modeling of the frequently sampled insulin-modified intravenous glucose tolerance test. Metabolism. 53(10). 1349–1354. 21 indexed citations
20.
Erichsen, Lars, et al.. (2003). Pharmacokinetic and Pharmacodynamic Properties of Insulin Aspart and Human Insulin. Journal of Pharmacokinetics and Pharmacodynamics. 30(3). 221–235. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Escher Breakdown of academic impact, for papers by Sunder Mudaliar Breakdown of academic impact, for papers by Takuhiro Sonoyama Breakdown of academic impact, for papers by R Stoltz Breakdown of academic impact, for papers by H. L. Krüskemper Breakdown of academic impact, for papers by Maria Mirabelli Breakdown of academic impact, for papers by Richard W Simpson Breakdown of academic impact, for papers by E. R. Ramey Breakdown of academic impact, for papers by Sabine Tunn Breakdown of academic impact, for papers by Taku Tsunekawa
Rankless by CCL
2026